Khiron Life Sciences Corp, a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has formed an exclusive strategic alliance with the Latin American Institute of Neurology and the Nervous System (“ILANS”), one of the most respected, fastest-growing, and largest health service provider networks in Colombia and Latin America. ILANS represents an estimated 100,000 patients, with the majority of these patients being located in Colombia. The alliance provides for research, technological product development, and evaluation and commercialization of products related to all aspects of medical cannabis.

Hemp Land, Cannabis Hemp Blog, 10/28/2020 06:18:02

Open article: